Cyclerion Therapeutics News and Activities

Cyclerion Therapeutics is a company listed under the stock ticker CYCN (US).

Acquisition, funding and merger involving Cyclerion Therapeutics.

• Korsana Biosciences and Cyclerion Therapeutics have merged  (posted on April 2 2026)..

View the org chart displaying its 7 main executives

Most searched biographies at Cyclerion Therapeutics

• Regina Graul, President and Chief Executive Officer and Director
• Peter Hecht, Director
• Dina Katabi, Director

Create your alert
to follow the executive moves at Cyclerion Therapeutics.

Cyclerion Therapeutics has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Cyclerion Therapeutics

• Cyclerion Announces Positive Data from IW-6463 CNS Translational Pharmacology Study in Healthy Elderly Subjects | Cyclerion Therapeutics, Inc.
• Cyclerion Announces Phase 2 STRONG-SCD Study Results in Patients with Sickle Cell Disease | Cyclerion Therapeutics, Inc.
• Cyclerion to Participate at Upcoming September 2020 Investor Conferences | Cyclerion Therapeutics, Inc.
• Cyclerion Announces Translational Research Award from the Alzheimer’s Association Part the Cloud-Gates Partnership Grant Program | Cyclerion Therapeutics, Inc.
• Cyclerion Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights | Cyclerion Therapeutics, Inc.
• Cyclerion Therapeutics Completes $24 Million Private Placement | Cyclerion Therapeutics, Inc.
• Cyclerion Therapeutics Presentation at Biomarkers in Alzheimer’s Disease Summit | Cyclerion Therapeutics, Inc.
• Cyclerion to Host Webcast Investor Event on July 9, 2020 | Cyclerion Therapeutics, Inc.
• Cyclerion Updates Corporate Progress | Cyclerion Therapeutics, Inc.
• Cyclerion announces IW-6463 phase 1 healthy volunteer study results that support further development for neurodegenerative diseases | Cyclerion Therapeutics, Inc.
• View more press releases Close

Social media about Cyclerion Therapeutics

• Cyclerion Therapeutics on Wikipedia, Google News & Yahoo Finance
• Cyclerion Therapeutics on LinkedIn, X (Twitter) & YouTube